Thomas Hanscom News Today

Researchers say they expect the worldwide number of cases of age-related macular degeneration to increase from the current 196 million to 288 million by 2040

A new study has linked a disrupted blood-retina barrier to Alzheimer's disease, suggesting that vascular changes in the eyes may be a driving factor.

Researchers say the drug aflibercept performed better in a clinical trial than bevacizumab in helping wean people off treatments for wet age-related macular degeneration